Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Announcement under Regulation 30 (LODR)-Updates on Acquisition

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE ·

This is to inform you that the Company ahs acquired 2,09,100 equity shares of Ishwari Healthcare Private Limited (51.00% of paid up equity share capital) at a revised consideration of Rs.1,50,00,000/- @ Rs.71.73/- per share. More details are provided in the letter to the BSE.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases